Cancer Testing Market to See Robust Growth through 2021, According to Insightful Report by IndustryARC Available at MarketPublishers.com24 Jun 2016 • by Natalie Aster
LONDON – Given manifold (over 100) existing types of cancer affecting people worldwide, there is a tremendous necessity of advanced, accurate, effective and appropriate screening tests that could perform the necessary diagnosis and also detect cancer as early as possible.
At present, the highest rate of cancer cases is registered in Denmark, Belgium, Australia, Norway, North Korea and Ireland; meanwhile, the lowest cancer rate is observed in such countries as Niger, Columbia, Nepal, Namibia, and Bhutan.
The global cancer testing/screening market is predicted to gain traction at a brisk pace from 2016 till 2021, spurred by a number of favorable factors including various technological advancements, innovations in cancer medicines, ongoing developments in the cancer diagnostics and also effective healthcare reforms.
Despite the high cost of cancer diagnosis, which is the key market growth restraint, the global cancer testing/screening market penetration is increasing due to government support and indigenous technologies from such countries as India, Japan and China.
Cutting-edge research study “Cancer Testing/Screening Market - By Techniques-Biomarker Test (PSA, CTC, AFP Tests); By Imaging (MRI Scan, CT Scan), By Technologies (NGS, QPCR, IHC), Applications, Geography - Forecasts 2016 - 2021” worked out by IndustryARC investigates the global market for cancer testing, provides data on the market share, value, volume and segmentation, examines the market dynamics and also explores the market competitive scenario. Major market growth drivers, challenges and limiters are analysed in this report along with a review of the emerging lucrative opportunities. Moreover, the report contains an overview of the possible scenario of the global cancer testing/screening market development through 2021.
More insightful research studies by IndustryARC are available at its page.